Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionKPP Advisory Services LLC
Latest Disclosed Ownership12,156 shares
Latest Disclosed Value $ 1,248,081
KPP Advisory Services LLC reports 0.84% decrease in ownership of ABL / Abbott Laboratories

On April 24, 2026 - KPP Advisory Services LLC filed a 13F-HR form disclosing ownership of 12,156 shares of Abbott Laboratories (DE:ABL) valued at $1,079,696 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 12,259 shares of Abbott Laboratories. This represents a change in shares of -0.84% during the quarter. The current value of the position is $914,374 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F ABBOTT LABORATORIES COM 002824100 12,156 -103 -0.84 1,248 -18.70 0.1813
2026-02-02 2025-12-31 13F ABBOTT LABS COM 002824100 12,259 520 4.43 1,536 -2.35 0.2231
2025-11-03 2025-09-30 13F ABBOTT LABS COM 002824100 11,739 335 2.94 1,572 1.35 0.2328
2025-07-30 2025-06-30 13F/A-1 ABBOTT LABS COM 002824100 11,404 -114,058 -90.91 1,551 11.42 0.2559
2025-07-23 2025-06-30 13F ABBOTT LABS COM 002824100 11,404 -114,058 1,551 0.3865
2025-04-23 2025-03-31 13F ABBOTT LABS COM 002824100 125,462 116,653 1,324.25 1,392 39.76 0.2640
2025-01-24 2024-12-31 13F ABBOTT LABS COM 002824100 8,809 422 5.03 996 4.18 0.2349
2024-11-06 2024-09-30 13F ABBOTT LABS COM 002824100 8,387 405 5.07 956 15.32 0.2295
2024-08-27 2024-06-30 13F ABBOTT LABS COM 002824100 7,982 768 10.65 829 1.22 0.2205
2024-05-14 2024-03-31 13F ABBOTT LABORATORIES Com 002824100 7,214 854 13.43 820 17.00 0.2251
2024-02-14 2023-12-31 13F ABBOTT LABORATORIES Common Stock 002824100 6,360 -303 -4.55 700 8.53 0.6151
2023-11-14 2023-09-30 13F ABBOTT LABORATORIES COM 002824100 6,663 6,663 645 0.2131
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.